1 / 23

Education in Palliative and End-of-life Care - Oncology

The. EPEC-O. TM. Education in Palliative and End-of-life Care - Oncology. Project. The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation.

collier
Download Presentation

Education in Palliative and End-of-life Care - Oncology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The EPEC-O TM Education in Palliative and End-of-life Care - Oncology Project The EPEC-O Curriculum is produced by the EPECTM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation.

  2. EPEC – Oncology Education in Palliative and End-of-life Care – Oncology Module 3g Symptoms – Delirium

  3. Delirium • A disturbance of consciousness • A change in cognition • Acute onset, fluctuating course APA Practice guideline. Am J Psychiatry, 1999.

  4. Associated changes • Day-night reversal • Emotional states • Non-specific neurological abnormalities • Decline in functional ability

  5. Types • Hyperactive • Associated behavioral disturbances • Hallucinations • Delusional beliefs • Hypoactive • Quiet • Mistaken for depression or fatigue • Mixed – waxing and waning

  6. Prevalence • 80 – 85 % of terminally ill patients

  7. Prognosis • Increased risk of • Complications • Protracted hospitalizations • Protracted postoperative recovery • 25 % delirious patients die < 6 months • In elderly, risk of dying during a hospital admission is 22 – 76 %

  8. Key points • Pathophysiology • Assessment • Management

  9. Infection Withdrawal Acute metabolic Trauma CNS pathology Hypoxia Deficiencies Endocrinopathies Acute vascular Toxins or drugs Heavy metals Causes of delirium . . .

  10. . . . Causes of delirium • Don’t forget • Constipation, fecal impaction • Urinary retention

  11. Neurophysiology • Multiple cortical, subcortical levels affected • Several neurotransmitters involved • Changes in regional cerebral perfusion

  12. Assessment • Clinical history, physical examination, serial observations • Folstein Mini-Mental State exam • Review of medication regimen • Thorough medical and laboratory work-up to elucidate underlying cause

  13. Delirium vs. dementia

  14. Management • Treat underlying causes • Non-pharmacological • Pharmacological • Consult psychiatrist for assistance

  15. Treat underlying causes • Medications • Anticholinergics • Analgesics • Ensure adequate hydration • Many other causes

  16. Non-pharmacological management • Environmental factors • Materials (like calendars, clocks) to reorient • Adequate soft lighting • Identify all individuals • Limit number of different individuals • Limit stimulation • Sitters for safety

  17. Pharmacological management • Antipsychotics • Haloperidol (non-sedating) • Chlorpromazine (sedating) • Risperidone (non-sedating) • Olanzapine (sedating) • Quetiapine (sedating)

  18. Day-night reversal • Use a sedating antipsychotic • Chlorpromazine • Olanzapine • Quetiapine

  19. Managing adverse effects • Dystonic reactions • Diphenhydramine • Akathisia, parkinsonian reactions • Benztropine • Tardive Dyskinesia • Stop medications • Consult psychiatry

  20. Benzodiazepines • Delirium due to alcohol withdrawal • For all other causes, not first line therapy • More likely cause disinhibition, particularly in elderly • Low dose with antipsychotic medications may be synergistic

  21. Reassess regularly • Monitor carefully • If negligible or partial response • Reevaluate diagnosis • Inquire about adherence to medication • Consider dosage adjustment • Consider a different medication • Refer to a specialist

  22. Terminal delirium • Delirium during the dying process • Signs of the dying process • Agitation, restlessness • Moaning, groaning • Multiple causes, irreversible • Lorazepam or midazolam to settle • Sedating antipsychotics Breitbart W, Strout D. Clin Geriatr Med, 2000.

  23. Summary Use comprehensive assessment and pathophysiology-based therapy to treat the cause and improve the cancer experience

More Related